Results 241 to 250 of about 8,044,473 (306)

The presence of CD11c+ B cells with potent effector memory phenotype in lung adenocarcinoma correlates with overall patient survival. [PDF]

Cancer Immunol Res
Sambanthamoorthy S, Ren Y, Galvez TK, King B, Liu SD, Kidd BA, Law DA, Baumgarth N.   +7 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Thymic B cells in aging and autoimmune disease. [PDF]

Front Immunol
Wedemeyer SA, Griffith AV.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Correction: Activated human B cells produce phospholipase D4-containing extracellular vesicles. [PDF]

PLoS One
PLOS One Staff.
europepmc   +1 more source

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

Molecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung, David Bickel, Lena C. M. Krause, Daria Ezeriņa, Christian Ickes, Julian Wojtachnia, Christine S. Gibhardt, Magdalena Shumanska, Khadija Wahni, Andrea Paluschkiwitz, Julia Malo Pueyo, Ekaterina Baranova, Wim Vranken, Hedwig Stanisz, Ioana Stejerean‐Todoran, Michael P. Schön, Joris Messens, Ivan Bogeski   +17 more
wiley   +1 more source

Intranasal booster drives class switching and homing of memory B cells for mucosal IgA response. [PDF]

JCI Insight
Chen S, Zhang Z, Lin Z, Yin L, Ning L, Liu W, Wang Q, Yang C, Feng B, Feng Y, Wang Y, Li H, He P, Liang H, Liu Y, Li Z, Liu B, Li Y, Boraschi D, Qu L, Niu X, Zhong N, Li P, Chen L.   +23 more
europepmc   +1 more source

B Cells Can Trigger the T-Cell-Mediated Autoimmune Response Against Melanocytes in Psoriasis. [PDF]

Cells
He M, Bernhardt M, Arakawa A, Kim SM, Vollmer S, Summer B, Arakawa Y, Ishimoto T, Schlosser A, Prinz JC.   +9 more
europepmc   +1 more source

The effect of Rituximab on B cells in pediatric autoimmune rheumatic diseases. [PDF]

North Clin Istanb
Baykal GO, Sozeri B.
europepmc   +1 more source

Activation of B1 B cells by F. tularensis atypical LPS depends on classical complement and C3a. [PDF]

PLoS Pathog
Melo G, Barbosa CHD, Magrini E, Garlanda C, Re F.   +4 more
europepmc   +1 more source